Hyperosmolar hyperglycemic state epidemiology and demographics
|
Hyperosmolar hyperglycemic state Microchapters |
|
Differentiating Hyperosmolar hyperglycemic state from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hyperosmolar hyperglycemic state epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Hyperosmolar hyperglycemic state epidemiology and demographics |
|
FDA on Hyperosmolar hyperglycemic state epidemiology and demographics |
|
CDC on Hyperosmolar hyperglycemic state epidemiology and demographics |
|
Hyperosmolar hyperglycemic state epidemiology and demographics in the news |
|
Blogs on Hyperosmolar hyperglycemic state epidemiology and demographics |
|
Risk calculators and risk factors for Hyperosmolar hyperglycemic state epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
The epidemiological parameters of the hyperosmolar hyperglycemic state (HHS) are difficult to predict because of lack of population-based studies in HHS. According to the national diabetes surveillance program of the centers for disease control (CDC), HHS accounts for less than 1000 hospital admissions per 100,000 diabetic admissions.
Epidemiology and Demographics
Incidence
- The exact incidence of the hyperosmolar hyperglycemic state is not known due to lack of population-based studies. However, according to the the national diabetes surveillance program of the centers for disease control (CDC), HHS accounts for less than 1000 hospital admissions per 100,000 diabetic admissions.[1][2]
- In the year 1995, the annual incidence of the hyperosmolar hyperglycemic state has been reported to be 17.5 persons per 100,000 persons per year.[3][1]
Case-fatality rate
- Case-fatality rate of hyperosmolar hyperglycemic state varies from a low of less than 5000 per 100,000 individuals to a high of 20,000 per 100,000 individuals.[2]
- Case-fatality rates of hyperosmolar hyperglycemic state differ according to the level of care provided and healthcare setting.[4]
Age
- The hyperosmolar hyperglycemic state commonly affects type 2 diabetic individuals older than 65 years years of age. It is less commonly seen in children and young adults.[2]
Race
- The prevalence and incidence of hyperosmolar hyperglycemic state is higher in black population.[5][1]
Gender
- The prevalence and incidence of hyperosmolar hyperglycemic state is higher in men as compared to women.[5]
References
- ↑ 1.0 1.1 1.2 Umpierrez GE, Kelly JP, Navarrete JE, Casals MM, Kitabchi AE (1997). "Hyperglycemic crises in urban blacks". Arch. Intern. Med. 157 (6): 669–75. PMID 9080921.
- ↑ 2.0 2.1 2.2 Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN (2009). "Hyperglycemic crises in adult patients with diabetes". Diabetes Care. 32 (7): 1335–43. doi:10.2337/dc09-9032. PMC 2699725. PMID 19564476.
- ↑ Lorber D (1995). "Nonketotic hypertonicity in diabetes mellitus". Med. Clin. North Am. 79 (1): 39–52. PMID 7808094.
- ↑ "Diabetes Care".
- ↑ 5.0 5.1 Farsani SF, Brodovicz K, Soleymanlou N, Marquard J, Wissinger E, Maiese BA (2017). "Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review". BMJ Open. 7 (7): e016587. doi:10.1136/bmjopen-2017-016587. PMID 28765134.